577
Views
5
CrossRef citations to date
0
Altmetric
Laboratory Study

Caffeic Acid Phenethyl Ester Protects Kidneys against Acetylsalicylic Acid Toxicity in Rats

, , , , , , , , , , & show all
Pages 1150-1155 | Received 05 Jun 2012, Accepted 18 Jul 2012, Published online: 06 Sep 2012

Figures & data

Table 1. Oxidant and antioxidant parameters in rat groups (mean ± standard deviation).

Figure 1. (A) Control group. Renal tubular structures (H&E, ×400). (B) ASA 50 mg group. Moderate cell swelling (arrow), some nuclear loss (arrowhead), and degenerative changes in tubular structures (H&E, ×400). (C) ASA 50 mg + CAPE group. Mild tubular cell swelling, some nuclear loss, and minimal degenerative changes in the tubules (H&E, ×400). (D) ASA 100 mg group. Prominent degenerative changes with cell swelling (arrows), much nuclear loss (arrowheads), nuclear pyknosis in the tubular cells, and moderate architectural impairment in the tubular structures (H&E, ×400). (E). ASA 100 mg + CAPE group. Improvement in the tubular structures, reduction of nuclear loss, and minimal cellular swelling compared with the ASA 100 mg group (Figure 1D) (H&E, ×400).

Figure 1. (A) Control group. Renal tubular structures (H&E, ×400). (B) ASA 50 mg group. Moderate cell swelling (arrow), some nuclear loss (arrowhead), and degenerative changes in tubular structures (H&E, ×400). (C) ASA 50 mg + CAPE group. Mild tubular cell swelling, some nuclear loss, and minimal degenerative changes in the tubules (H&E, ×400). (D) ASA 100 mg group. Prominent degenerative changes with cell swelling (arrows), much nuclear loss (arrowheads), nuclear pyknosis in the tubular cells, and moderate architectural impairment in the tubular structures (H&E, ×400). (E). ASA 100 mg + CAPE group. Improvement in the tubular structures, reduction of nuclear loss, and minimal cellular swelling compared with the ASA 100 mg group (Figure 1D) (H&E, ×400).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.